Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $9.41, but opened at $9.00. Aspen Pharmacare shares last traded at $9.00, with a volume of 1,160 shares trading hands.
Aspen Pharmacare Price Performance
The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.66 and a current ratio of 3.64. The business has a 50-day simple moving average of $8.79 and a two-hundred day simple moving average of $7.97.
Aspen Pharmacare Company Profile
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Further Reading
- Five stocks we like better than Aspen Pharmacare
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
